Skip to content
ClinCalc Pro
Menu
Aminopenicillin Antibiotic

Ampicillin

Brand names: Penbritin

Ampicillin is a broad-spectrum aminopenicillin antibiotic used for susceptible infections including certain respiratory, urinary, gastrointestinal and listerial infections.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits bacterial cell wall synthesis by binding penicillin-binding proteins, leading to bacterial lysis.

Prescribing in practice

  • It is contraindicated in patients with penicillin hypersensitivity, who are at risk of anaphylaxis.
  • A maculopapular rash is common if given in glandular fever (infectious mononucleosis) and it should be avoided in this setting.
  • Many common organisms produce beta-lactamases conferring resistance, so therapy should be guided by susceptibility where possible.

Monitoring

Monitor for hypersensitivity reactions and clinical response, and review renal and hepatic function with prolonged or high-exposure treatment.

Counselling the patient

  • Report any rash, swelling or breathing difficulty, which may indicate allergy.
  • Complete the full prescribed course even if you feel better.
  • Tell your prescriber if you have ever reacted to a penicillin.

Evidence & guidelines

Ampicillin and related aminopenicillins are long-established agents with well-defined roles in UK antimicrobial guidance.

Reference: BSAC Endocarditis Guidelines (2012 updated); NICE NG51 (Meningitis); PHE/UKHSA antibiotic guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.